-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0New Approaches Lessen Mystery of Cancer of Unknown Primary - 4 year(s) ago
Almost half of patients with cancer of unknown primary have ‘actionable’ findings on genomic sequencing that could lead to targeted therapy, although the impact on outcomes is unclear, say experts.
Source: MedscapeCategories: Hem/Oncs, Latest HeadlinesTweet-
New Approaches Lessen Mystery of Cancer of Unknown Primary: But Clinical Benefits Not Established [Jun 11, 2020] Liam Davenport @MedscapeOnc https://t.co/FXY0yAHTMO #CUPsm #PrecisionMedicine
-
-
Mashup Score: 0New Approaches Lessen Mystery of Cancer of Unknown Primary - 4 year(s) ago
Almost half of patients with cancer of unknown primary have ‘actionable’ findings on genomic sequencing that could lead to targeted therapy, although the impact on outcomes is unclear, say experts.
Source: MedscapeCategories: Hem/Oncs, Latest HeadlinesTweet-
New Approaches Lessen Mystery of Cancer of Unknown Primary: But Clinical Benefits Not Established [Jun 11, 2020] Liam Davenport @MedscapeOnc https://t.co/FXY0yAHTMO #CUPsm #PrecisionMedicine
-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb8GOT & https://t.co/6vxGpOvDFh #PrecisionMedicine #CUPsm @TempusLabs